Ultravist 300 and Haematomyelia - from FDA reports


Summary

There is no Haematomyelia reported by people who take Ultravist 300 yet. This review analyzes which people have Haematomyelia with Ultravist 300. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Ultravist 300 and have Haematomyelia, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 11, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Haematomyelia when taking Ultravist 300?

Expand the study to include all drugs with the same ingredients

Haematomyelia and drugs with ingredients of iopromide.

Expand the study to include reports from both FDA and eHealthMe

Haematomyelia and Ultravist 300 from FDA and eHealthMe reports

Ultravist 300

Ultravist 300 has active ingredients of iopromide. (latest outcomes from Ultravist 300 2,780 users)

Haematomyelia

Haematomyelia (intramedullary spinal cord haemorrhage) has been reported by people with atrial fibrillation/flutter (latest reports from 1 Haematomyelia patients).

Browse all side effects of Ultravist 300

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Haematomyelia

Haematomyelia

Could your condition cause Haematomyelia

Haematomyelia

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Ultravist 300 and have Haematomyelia.